Bicara Therapeutics Inc. Common Stock Insider Transactions
Bicara Therapeutics Inc. Common Stock Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Raben David
Chief Medical Officer |
Sell | 906 @ $18.84 | $17.07 K | 35,497 | 11/25/2025 | 11/25/2025 | |
|
Mazumdar Claire
CEO |
Sell | 41,163 @ $18.86 | $776.43 K | 309,892 | 11/24/2025 | 11/25/2025 | |
|
Raben David
Chief Medical Officer |
Sell | 5,500 @ $18.45 | $101.48 K | 35,497 | 11/24/2025 | 11/25/2025 | |
|
Hyep Ivan
CFO |
Sell | 17,795 @ $18.55 | $330.09 K | 145,355 | 11/24/2025 | 11/25/2025 | |
|
Cohlhepp Ryan
Director, President and COO |
Sell | 4,500 @ $18.05 | $81.21 K | 193,641 | 11/21/2025 | 11/25/2025 | |
|
Hyep Ivan
CFO |
Sell | 605 @ $18.15 | $10.98 K | 145,355 | 11/21/2025 | 11/25/2025 | |
|
Cohlhepp Ryan
Director, President and COO |
Sell | 8,000 @ $18.05 | $144.38 K | 198,141 | 11/21/2025 | 11/25/2025 | |
|
Mazumdar Claire
CEO |
Sell | 13,289 @ $18.84 | $250.39 K | 309,892 | 10/15/2025 | 10/15/2025 | |
|
Cohlhepp Ryan
Director, President and COO |
Sell | 4,500 @ $18.16 | $81.70 K | 198,141 | 10/15/2025 | 10/16/2025 | |
|
Cohlhepp Ryan
Director, President and COO |
Sell | 8,000 @ $18.16 | $145.24 K | 202,641 | 10/15/2025 | 10/16/2025 | |
|
Mazumdar Claire
CEO |
Sell | 11,445 @ $18.92 | $216.55 K | 309,892 | 10/13/2025 | 10/15/2025 | |
|
Raben David
Chief Medical Officer |
Sell | 22,000 @ $18.45 | $405.90 K | 35,497 | 10/09/2025 | 10/10/2025 | |
|
Hyep Ivan
CFO |
Sell | 6,415 @ $18.23 | $116.93 K | 145,355 | 10/09/2025 | 10/10/2025 | |
|
Hyep Ivan
CFO |
Sell | 5,627 @ $18.21 | $102.46 K | 145,355 | 10/08/2025 | 10/08/2025 | |
|
Hyep Ivan
CFO |
Sell | 18,244 @ $18.22 | $332.39 K | 145,355 | 10/07/2025 | 10/08/2025 | |
|
Cohlhepp Ryan
Director, President and COO |
Sell | 8,000 @ $18.06 | $144.47 K | 205,541 | 10/07/2025 | 10/08/2025 | |
|
Cohlhepp Ryan
Director, President and COO |
Sell | 2,900 @ $18.06 | $52.37 K | 202,641 | 10/07/2025 | 10/08/2025 | |
|
Cohlhepp Ryan
Director, President and COO |
Sell | 24,000 @ $18.06 | $433.33 K | 221,141 | 10/06/2025 | 10/08/2025 | |
|
Hyep Ivan
CFO |
Sell | 6,514 @ $18.17 | $118.36 K | 145,355 | 10/06/2025 | 10/08/2025 | |
|
Cohlhepp Ryan
Director, President and COO |
Sell | 15,600 @ $18.06 | $281.67 K | 205,541 | 10/06/2025 | 10/08/2025 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Bicara Therapeutics Inc. Common Stock FAQ's
The list of insiders at Bicara Therapeutics Inc. Common Stock includes Meisner Lara, Hyep Ivan, Cohlhepp Ryan, Raben David, Mazumdar Claire.
Insiders have sold a total of 369.61 K Bicara Therapeutics Inc. Common Stock shares in the last 12 months for a total of 6.01 M sold.
The following insiders have sold Bicara Therapeutics Inc. Common Stock shares in the last 12 months: Meisner Lara ($1.87 M), Hyep Ivan ($1.01 M), Cohlhepp Ryan ($1.36 M), Raben David ($524.45 K), Mazumdar Claire ($1.24 M),